Marks, L. J., Ritter, V., Agrusa, J., Kamdar, K. Y., Rivers, J., Gardner, R. A., Ehrhardt, M. J., Devine, K. J., Phillips, C. A., Reilly, A. F., August, K., Weinstein, J. L., Satwani, P., Forlenza, C. J., Smith, C. M., Greer, C., Afify, Z., Lin, C. H., Belsky, J. A., … Aftandilian, C. (2025). Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014745
Subjects:
Anaplastic Lymphoma Kinase
(MeSH)
Lymphoid Neoplasms
(OpenAlex Topic)
Advancements in Lung Cancer Research
(OpenAlex Topic)
Sarcoma Research and Treatment
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2024014745
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex